Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Exosomes in Human Carcinogenesis and Cancer Therapy-Recent Findings from Molecular and Clinical Research. | Cells | 2023 | 36766698 | PubTator, text mining | PubMed |
| Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer. | Cancers (Basel) | 2023 | 36765690 | PubTator, text mining | PubMed |
| Parallelized multidimensional analytic framework applied to mammary epithelial cells uncovers regulatory principles in EMT. | Nat Commun | 2023 | 36755019 | PubTator, text mining | PubMed |
| Role of genetic factors in different swine breeds exhibiting varying levels of resistance/susceptibility to PRRSV. | Virus Res | 2023 | 36731630 | PubTator, text mining | PubMed |
| Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma. | Nat Commun | 2023 | 36707509 | PubTator, text mining | PubMed |
| Graphene-Based Field-Effect Transistors in Biosensing and Neural Interfacing Applications: Recent Advances and Prospects. | Anal Chem | 2023 | 36693046 | PubTator, text mining | PubMed |
| Meiotic chromosome organization and its role in recombination and cancer. | Curr Top Dev Biol | 2023 | 36681479 | PubTator, text mining | PubMed |
| Stem Cells for Cancer Therapy: Translating the Uncertainties and Possibilities of Stem Cell Properties into Opportunities for Effective Cancer Therapy. | Int J Mol Sci | 2023 | 36674525 | PubTator, text mining | PubMed |
| Advances in Lung Cancer Treatment Using Nanomedicines. | ACS Omega | 2023 | 36643475 | PubTator, text mining | PubMed |
| Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma. | BMC Cancer | 2023 | 36624401 | PubTator, text mining | PubMed |
| Recent advances of bioactive proteins/polypeptides in the treatment of breast cancer. | Food Sci Biotechnol | 2023 | 36619215 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives. | Int J Mol Sci | 2023 | 36614326 | PubTator, text mining | PubMed |
| Targeted surface marker screening on neuronal structures in the human choroid. | Exp Eye Res | 2023 | 36586549 | PubTator, text mining | PubMed |
| Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir. | Nat Immunol | 2023 | 36536105 | PubTator, text mining | PubMed |
| Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome. | Mol Oncol | 2023 | 36520032 | PubTator, text mining | PubMed |
| TSPAN4 and migrasomes in atherosclerosis regression correlated to myocardial infarction and pan-cancer progression. | Cell Adh Migr | 2023 | 36513632 | PubTator, text mining | PubMed |
| CD151 and prostate cancer progression: A review of current literature. | Asia Pac J Clin Oncol | 2023 | 36448565 | PubTator, text mining | PubMed |
| KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification. | Cancer Med | 2023 | 36420693 | PubTator, text mining | PubMed |
| Fibroblasts secrete fibronectin under lamellipodia in a microtubule- and myosin II-dependent fashion. | J Cell Biol | 2023 | 36416725 | PubTator, text mining | PubMed |
| CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma. | Int J Cancer | 2023 | 36250346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=14